increased cardiac muscle contractility_Raf1<tm2.1Ara>/Raf1<tm2.1Ara>

http://metadb.riken.jp/0005599I129S6SvEvTacC57BL6NCrRaf1tm21AraRaf1tm21AraRaf1tm21Ara

increased cardiac muscle contractility_Raf1<tm2.1Ara>/Raf1<tm2.1Ara>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• v-raf-leukemia viral oncogene 1
  http://metadb.riken.jp/db/mgi_rdf/MGI:97847

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Raf1<tm2.1Ara>/Raf1<tm2.1Ara>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Raf1<tm2.1Ara>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S6/SvEvTac * C57BL/6NCr

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased cardiac muscle contractility
  http://purl.obolibrary.org/obo/MP_0005599

文献

http://purl.org/net/cito/citesAsAuthority

• Xue. Wu, et.al., Increased BRAF heterodimerization is the common pathogenic mechanism for noonan syndrome-associated RAF1 mutants., Molecular and cellular biology, 2012, 32
  http://rdf.ncbi.nlm.nih.gov/pubmed/22826437